Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Landman

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|April 23, 2019
<i>In Vitro</i> and <i>In Vivo</i> Activity of a Novel Antisense Peptide Nucleic Acid Compound Against Multidrug-Resistant <i>Acinetobacter baumannii</i>Michael Rose, Amabel Lapuebla, David Landman, et al.
Journal of Clinical Microbiology|September 2, 2011
Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpointsDavid Landman, Julius Salamera, Manisha Singh, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2005
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin BDavid Landman, Simona Bratu, Maqsood Alam, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2020
Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3Saquib Malik, Monica Kaminski, David Landman, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2019
Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centresZeb Khan, Alejandro Iregui, David Landman, et al.
Clinical Microbiology Reviews|July 16, 2008
Polymyxins revisitedDavid Landman, Claudiu Georgescu, Don Antonio Martin, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 8, 2017
Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York CityNyla Manning, Gregory Balabanian, Michael Rose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2019
Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, New YorkAlejandro Iregui, Zeb Khan, Saquib Malik, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 22, 2018
Effect of Porins and bla<sub>KPC</sub> Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?Gregory Balabanian, Michael Rose, Nyla Manning, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2009
Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York CitySimona Bratu, David Landman, Avrille George, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Microbial Drug Resistance (Larchmont, N.Y.)|April 23, 2019
<i>In Vitro</i> and <i>In Vivo</i> Activity of a Novel Antisense Peptide Nucleic Acid Compound Against Multidrug-Resistant <i>Acinetobacter baumannii</i>Michael Rose, Amabel Lapuebla, David Landman, et al.
Journal of Clinical Microbiology|September 2, 2011
Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpointsDavid Landman, Julius Salamera, Manisha Singh, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2005
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin BDavid Landman, Simona Bratu, Maqsood Alam, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2020
Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3Saquib Malik, Monica Kaminski, David Landman, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2019
Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centresZeb Khan, Alejandro Iregui, David Landman, et al.
Clinical Microbiology Reviews|July 16, 2008
Polymyxins revisitedDavid Landman, Claudiu Georgescu, Don Antonio Martin, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 8, 2017
Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York CityNyla Manning, Gregory Balabanian, Michael Rose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2019
Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, New YorkAlejandro Iregui, Zeb Khan, Saquib Malik, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 22, 2018
Effect of Porins and bla<sub>KPC</sub> Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?Gregory Balabanian, Michael Rose, Nyla Manning, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2009
Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York CitySimona Bratu, David Landman, Avrille George, et al.
Pageof 6